Effect of Doxorubicin on Squamous Cell Carcinoma of Skin: Assessment by MRI Relaxometry at 4.7T

Cancer Invest. 2019;37(8):339-354. doi: 10.1080/07357907.2019.1651327. Epub 2019 Aug 14.

Abstract

Squamous cell carcinoma (SCC) of skin has no standard treatment regimen, resulting in recurrences/metastasis. Although, doxorubicin (Dox), an anthracycline antibiotic has demonstrated some degree of efficacy. Molecular imaging can help in assessment of treatment response and prognosis of SCCs. MRI data showed that spin-spin relaxation (T2) time was longer (138 ± 2 msec) in Dox treated Test-II and there is no significant difference in spin-lattice relaxation (T1) time with respective controls. These findings further corroborated with the histology, proliferation index, apoptotic index, and HMGA1 protein expression. Thus, MRI may be a useful tool for monitoring treatment response noninvasively for skin tumor prognosis.

Keywords: MRI; Skin tumor; benzo(a)pyrene and HMGA1 proteins; doxorubicin; spin-lattice Relaxation Time (T1); spin-spin Relaxation Time (T2).

MeSH terms

  • Animals
  • Antibiotics, Antineoplastic / pharmacology*
  • Apoptosis / drug effects
  • Biomarkers / metabolism
  • Carcinoma, Squamous Cell / diagnostic imaging
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / metabolism
  • Carcinoma, Squamous Cell / pathology
  • Doxorubicin / pharmacology*
  • HMGA Proteins / genetics
  • HMGA Proteins / metabolism
  • Magnetic Resonance Imaging*
  • Mice
  • Molecular Imaging / methods*
  • Predictive Value of Tests
  • Skin Neoplasms / diagnostic imaging
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / metabolism
  • Skin Neoplasms / pathology
  • Time Factors
  • Tumor Burden / drug effects

Substances

  • Antibiotics, Antineoplastic
  • Biomarkers
  • HMGA Proteins
  • Doxorubicin